002294 Shenzhen Salubris Pharmaceuticals
- 32.56
- +0.20+0.62%
Shenzhen Salubris Pharmaceuticals News
Xinlitai: Huaying Securities Co., Ltd.\'s inspection opinion on the adjustment and extension of the internal investment structure of some fund-raising projects of Shenzhen Xinlitai Pharmaceutical Co., Ltd.
Xinlitai: Announcement of Resolutions of the Fourth Meeting of the 6th Board of Supervisors
Xinlitai: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Xinlitai: Announcement of Resolutions of the Fourth Meeting of the 6th Board of Directors
Shenzhen Salubris Pharmaceuticals: Announcement regarding the pharmaceutical registration certificate for Benzoic Acid Voglibose Tablets (Xinlitin)
Shenzhen Salubris Pharmaceuticals: Announcement regarding Sun Company providing guarantee for its subsidiary.
Shenzhen Salubris Pharmaceuticals: Notice on obtaining a drug registration certificate for alisartan ester amlodipine tablets (foritan)
Xinlitai: Announcement of Resolutions of the Third Meeting of the 6th Board of Directors
Xinlitai: 002294 Xinlitai performance briefing, roadshow event information 20240415
Xinlitai: Announcement on holding the 2023 Annual Results Briefing
Xinlitai: Announcement on Cancelling Some Special Fund Raising Accounts
Xinlitai: 2023 Annual Audit Report
Xinlitai: Feasibility Analysis Report on Launching a Hedging Financial Derivatives Trading Business
Xinlitai: Annual Special Audit Report on Related Party Capital Occupation
Xinlitai: Annual Verification Report on the Use of Funds Raised
Xinlitai: Special opinion of the board of directors on the evaluation of the independence of independent directors
Xinlitai: Announcement of Resolutions of the Second Meeting of the 6th Board of Supervisors
Xinlitai: Report on the work of the Supervisory Committee in 2023
Xinlitai: Special instructions on the use of annual funds raised
Xinlitai: 2023 Independent Director Debriefing Report (Wang Xuegong)
Analysis
Price Target
No Data
No Data